The abstract is read at the publisher; the summary is JClub's.
Lower achieved LDL cholesterol after statin initiation in 185,237 primary-prevention patients is linked to reduced major adverse cardiovascular events, with the strongest contrast versus LDL ≥2.6 mmol/L.
- Why it matters: Guideline targets for LDL and non-HDL cholesterol in primary prevention are uncertain, and clinicians need evidence on whether lower achieved levels after starting statins relate to cardiovascular outcomes and death.
- What they did: Using electronic healthcare databases from Hong Kong, New Zealand, and the UK, landmark multivariable Cox models assessed LDL and non-HDL cholesterol measured within 2 years post-initiation for MACE and all-cause mortality, with random-effects meta-analysis.
- The result: Compared with LDL ≥2.6 mmol/L, adjusted HRs for MACE were 0.80 (95% CI 0.77–0.83) for 1.8–2.5 mmol/L, 0.79 (0.66–0.94) for 1.4–1.7 mmol/L, and 0.82 (0.60–1.12) for <1.4 mmol/L; very low LDL and non-HDL were not associated with all-cause mortality after adjustment.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.